CHANGE IN REGULATORY SCIENCES IN THE EU

CHANGE IN REGULATORY SCIENCES IN THE EU

Change in Regulatory Sciences is a continuous challenging process! The challenge is to align scientific and patients’ objectives with regulatory requirements along the whole development process of health products. Moreover, all the stakeholders should be aware of the criteria by which the authorisation and access to products will be measured and decided to cover patients’ specific needs.

c4c, better medicines for babies, children and young people

c4c, better medicines for babies, children and young people

c4c (conect4children) is a 6-years EU project setting up a large collaborative paediatric network that will facilitate the development of new drugs and other therapies for the entire paediatric population in Europe. 33 academic and 10 industry partners, more than 50 third parties and around 500 affiliated partners work together to build capacity for the implementation of multinational paediatric clinical trials whilst ensuring the needs of babies, children, young...

Pin It on Pinterest